YOLO250117P3000
- 0.55
- 0.000.00%
Advisorshares Pure Cannabis Etf Newsroom
Executive Reshuffles: BA, EXPE, TPVG and GEO
Advanced Flower Capital Analyst Ratings
Jazz Pharmaceuticals Announces CEO Succession Plan; Bruce Cozadd, Co-Founder, Chairperson And CEO, Plans To Retire As CEO Upon Appointment Of Successor By The End Of 2025; Will Continue As Chair Of The Board; Jazz Remains On Track To Meet Its FY24...
Dropbox Shares Are Trading Higher After the Company Secured a $2 Billion Term Loan Facility Led by Blackstone, Authorized a $1.2 Billion Share Repurchase Program, and Stated It Expects to Meet or Exceed Q4 and FY 2024 Guidance.
Express News | Dropbox Shares Are Trading Higher After the Company Secured a $2 Billion Term Loan Facility Led by Blackstone, Authorized a $1.2 Billion Share Repurchase Program, and Stated It Expects to Meet or Exceed Q4 and FY 2024 Guidance
RBC Capital Reiterates Outperform on Jazz Pharmaceuticals, Maintains $179 Price Target
This Cannabis REIT Offers 13%+ Yield, Safer Returns Than Fed-Backed Bonds
CBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive Improvements
Zuanic & Associates Maintains Overweight on Chicago Atlantic Realto Overweight
Chicago Atlantic Real Analyst Ratings
Jazz Pharmaceuticals To Showcase New Real-World Evidence Reinforcing Epidiolex Benefits And Broad-Spectrum Efficacy In Treatment-Resistant Epilepsies At AES 2024 Annual Meeting
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand
Better Than The Bank: Weed Real Estate Investment Company's 14% Yield Beats Traditional Savings
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow
Initial Hearing on Marijuana Rescheduling Set for Dec. 2
'Federal Health Officials 'Rejected' DEA's Request To Testify At Marijuana Rescheduling Hearing, Agency Tells Judge' - Marijuana Moment
'Democratic Congressional Lawmakers Push Biden To Issue Marijuana Executive Order Before Trump Takes Office' - Marijuana Moment
Tom Angell Says "DEA Says It Is in the Process of Preparing Public Access to the Cannabis Rescheduling Proceedings Docket. For Now, Read Marijuana Moment's Coverage of the Latest Significant Filings:", 'DEA And Anti-Marijuana Group Deny Allegations...
Cannabis Stocks Feel The Burn: Matt Gaetz Bows Out As Trump's Attorney General Nominee
Baird Maintains Outperform on Jazz Pharmaceuticals, Raises Price Target to $162